{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:06:43Z","timestamp":1768464403038,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The primary triggers that stimulate the body to generate platelet antibodies via immune mechanisms encompass events such as pregnancy, transplantation, and blood transfusion. Interestingly, our findings revealed that a subset of male patients with hepatocellular carcinoma (HCC), despite having no history of transplantation or blood transfusion, has shown positive results in platelet antibody screenings. This hints at the possibility that certain factors, potentially related to the tumor itself or its treatment, may affect antibody production. To delve the causes we initiated this study. We employed a case\u2013control study approach to analyze potential influential factors leading to the positive results via univariate and multivariate regression analysis. We utilized Kendall\u2019s tau-b correlation to examine the relationship between the strength of platelet antibodies and peripheral blood cytopenia. Antitumor medication emerged as an independent risk factor for positive results in HCC patients, and the strength of platelet antibodies positively correlated with the severity of anemia and thrombocytopenia. Without history of blood transfusion, transplantation, pregnancy, those HCC patients underwent recent tumor medication therapy are experiencing peripheral erythrocytopenia or thrombocytopenia, for them platelet antibody screenings holds potential clinical value for prevention and treatment of complications like drug-immune-related anemia and\/or bleeding.<\/jats:p>","DOI":"10.1038\/s41598-024-60603-8","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T12:01:47Z","timestamp":1714219307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of the correlation between platelet antibodies and peripheral blood cytopenia in patients with hepatocellular carcinoma"],"prefix":"10.1038","volume":"14","author":[{"given":"Rui","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Chan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Tao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Yang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Jian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Qian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,27]]},"reference":[{"key":"60603_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ajcp\/aqy121","volume":"151","author":"AE Schmidt","year":"2019","unstructured":"Schmidt, A. E., Refaai, M. A. & Coppage, M. HLA-mediated platelet refractoriness. Am. J. Clin. Pathol. 151, 353\u2013363. https:\/\/doi.org\/10.1093\/ajcp\/aqy121 (2019).","journal-title":"Am. J. Clin. Pathol."},{"key":"60603_CR2","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1111\/trf.14316","volume":"57","author":"JE Juskewitch","year":"2017","unstructured":"Juskewitch, J. E. et al. How do I \u2026 manage the platelet transfusion-refractory patient?. Transfusion 57, 2828\u20132835. https:\/\/doi.org\/10.1111\/trf.14316 (2017).","journal-title":"Transfusion"},{"key":"60603_CR3","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/trf.16181","volume":"61","author":"H Inoue","year":"2021","unstructured":"Inoue, H. et al. Minor impact of patient alloantibodies against human platelet antigen (HPA)-15 in the effectiveness of platelet transfusion: A pilot study. Transfusion 61, 738\u2013743. https:\/\/doi.org\/10.1111\/trf.16181 (2021).","journal-title":"Transfusion"},{"key":"60603_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/vox.12725","volume":"114","author":"M Kjaer","year":"2019","unstructured":"Kjaer, M. et al. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal\/Neonatal Alloimmune Thrombocytopenia: A systematic review. Vox Sang. 114, 79\u201394. https:\/\/doi.org\/10.1111\/vox.12725 (2019).","journal-title":"Vox Sang."},{"key":"60603_CR5","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.humimm.2012.07.332","volume":"73","author":"B Sis","year":"2012","unstructured":"Sis, B. Endothelial molecules decipher the mechanisms and functional pathways in antibody-mediated rejection. Hum. Immunol. 73, 1218\u20131225. https:\/\/doi.org\/10.1016\/j.humimm.2012.07.332 (2012).","journal-title":"Hum. Immunol."},{"key":"60603_CR6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41581-018-0039-x","volume":"14","author":"RA Montgomery","year":"2018","unstructured":"Montgomery, R. A., Tatapudi, V. S., Leffell, M. S. & Zachary, A. A. HLA in transplantation. Nat. Rev. Nephrol. 14, 558\u2013570. https:\/\/doi.org\/10.1038\/s41581-018-0039-x (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"60603_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/labmed\/lmz004","volume":"50","author":"C Milito","year":"2019","unstructured":"Milito, C. et al. Post-transfusion purpura mimicking idiopathic thrombocytopenic purpura: A case report. Lab. Med. 50, 396\u2013400. https:\/\/doi.org\/10.1093\/labmed\/lmz004 (2019).","journal-title":"Lab. Med."},{"key":"60603_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.transci.2014.12.028","volume":"52","author":"H Brouk","year":"2015","unstructured":"Brouk, H. et al. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness. Transfus. Apher. Sci. 52, 295\u2013299. https:\/\/doi.org\/10.1016\/j.transci.2014.12.028 (2015).","journal-title":"Transfus. Apher. Sci."},{"key":"60603_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1046\/j.1537-2995.2001.41060771.x","volume":"41","author":"PK Martin-Kurz","year":"2001","unstructured":"Martin-Kurz, P. K., Peter, K., Hildegard, T. G., Paul, H. & Simon, P. Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments: A comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test. Transfusion 41, 771\u2013774 (2001).","journal-title":"Transfusion"},{"key":"60603_CR10","first-page":"888","volume":"15","author":"X De-Yi","year":"2007","unstructured":"De-Yi, X. et al. Application of microcolumn gel immunoassay in screening the platelet antibody. J. Exp. Hematol. 15, 888\u2013891 (2007).","journal-title":"J. Exp. Hematol."},{"key":"60603_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-3148.1991.tb00026.x","volume":"1","author":"JA Lown","year":"1991","unstructured":"Lown, J. A. & Ivey, J. G. Evaluation of a solid phase red cell adherence technique for platelet antibody screening. Transfus. Med. 1, 163\u2013167. https:\/\/doi.org\/10.1111\/j.1365-3148.1991.tb00026.x (1991).","journal-title":"Transfus. Med."},{"key":"60603_CR12","doi-asserted-by":"publisher","first-page":"102705","DOI":"10.1016\/j.transci.2019.102705","volume":"59","author":"L Porcelijn","year":"2020","unstructured":"Porcelijn, L., Huiskes, E. & de Haas, M. Progress and development of platelet antibody detection. Transfus. Apher. Sci. 59, 102705. https:\/\/doi.org\/10.1016\/j.transci.2019.102705 (2020).","journal-title":"Transfus. Apher. Sci."},{"key":"60603_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/vox.12085","volume":"106","author":"BR Curtis","year":"2014","unstructured":"Curtis, B. R. & McFarland, J. G. Human platelet antigens - 2013. Vox Sang. 106, 93\u2013102. https:\/\/doi.org\/10.1111\/vox.12085 (2014).","journal-title":"Vox Sang."},{"key":"60603_CR14","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/ajh.23503","volume":"88","author":"NM Heikal","year":"2013","unstructured":"Heikal, N. M. & Smock, K. J. Laboratory testing for platelet antibodies. Am. J. Hematol. 88, 818\u2013821. https:\/\/doi.org\/10.1002\/ajh.23503 (2013).","journal-title":"Am. J. Hematol."},{"key":"60603_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/jth.12052","volume":"11","author":"DM Arnold","year":"2013","unstructured":"Arnold, D. M. et al. A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J. Thromb. Haemost. 11, 169\u2013176. https:\/\/doi.org\/10.1111\/jth.12052 (2013).","journal-title":"J. Thromb. Haemost."},{"key":"60603_CR16","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/annonc\/mds074","volume":"23","author":"DL Jardim","year":"2012","unstructured":"Jardim, D. L., Rodrigues, C. A., Novis, Y. A. S., Rocha, V. G. & Hoff, P. M. Oxaliplatin-related thrombocytopenia. Ann. Oncol. 23, 1937\u20131942. https:\/\/doi.org\/10.1093\/annonc\/mds074 (2012).","journal-title":"Ann. Oncol."},{"key":"60603_CR17","doi-asserted-by":"publisher","first-page":"e10507","DOI":"10.7759\/cureus.10507","volume":"12","author":"J Moore","year":"2020","unstructured":"Moore, J., Baer, M. R., Grover, B. E., Aster, R. H. & Millstein, L. S. Moxifloxacin-induced thrombocytopenia mediated by moxifloxacin-dependent IgM and IgG antiplatelet antibodies: A case report. Cureus 12, e10507. https:\/\/doi.org\/10.7759\/cureus.10507 (2020).","journal-title":"Cureus"},{"key":"60603_CR18","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.2169\/internalmedicine.4785-20","volume":"59","author":"R Taguchi","year":"2020","unstructured":"Taguchi, R. et al. Thrombocytopenia caused by dexamethasone in a patient with colorectal cancer. Intern. Med. 59, 2571\u20132575. https:\/\/doi.org\/10.2169\/internalmedicine.4785-20 (2020).","journal-title":"Intern. Med."},{"key":"60603_CR19","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.3390\/jcm9072212","volume":"9","author":"C Vayne","year":"2020","unstructured":"Vayne, C. et al. Pathophysiology and diagnosis of drug-induced immune thrombocytopenia. J. Clin. Med. 9, 2212. https:\/\/doi.org\/10.3390\/jcm9072212 (2020).","journal-title":"J. Clin. Med."},{"key":"60603_CR20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","volume":"113","author":"SG Johansson","year":"2004","unstructured":"Johansson, S. G. et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J. Allergy Clin. Immunol. 113, 832\u2013836. https:\/\/doi.org\/10.1016\/j.jaci.2003.12.591 (2004).","journal-title":"J. Allergy Clin. Immunol."},{"key":"60603_CR21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1055\/a-0962-6361","volume":"145","author":"O Hidiatov","year":"2020","unstructured":"Hidiatov, O., Zlamal, J., Aidery, P. & Bakchoul, T. Acquired immune thrombocytopenia: An update on aspects of diagnosis and management relevant for intensive care medicine. Dtsch. Med. Wochenschr. 145, 747\u2013753. https:\/\/doi.org\/10.1055\/a-0962-6361 (2020).","journal-title":"Dtsch. Med. Wochenschr."},{"key":"60603_CR22","first-page":"1","volume":"11","author":"LT Eric","year":"2019","unstructured":"Eric, L. T., Padma, L. D., Jennifer, A. P. & Sidhu, G. S. Acute immune-mediated thrombocytopenia due to oxaliplatin and irinotecan therapy. Oncol. Med. 11, 1\u20135 (2019).","journal-title":"Oncol. Med."},{"key":"60603_CR23","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMra066469","volume":"357","author":"RH Aster","year":"2007","unstructured":"Aster, R. H. & Bougie, D. W. Drug-induced immune thrombocytopenia. New Engl. J. Med. 357, 580\u2013587 (2007).","journal-title":"New Engl. J. Med."},{"key":"60603_CR24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1537-2995.2005.04373.x","volume":"45","author":"BM Taleghani","year":"2005","unstructured":"Taleghani, B. M. et al. Oxaliplatin-induced immune pancytopenia. Transfusion 45, 704\u2013708. https:\/\/doi.org\/10.1111\/j.1537-2995.2005.04373.x (2005).","journal-title":"Transfusion"},{"key":"60603_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/1078155213520262","volume":"21","author":"NP Forcello","year":"2015","unstructured":"Forcello, N. P., Khubchandani, S., Patel, S. J. & Brahaj, D. Oxaliplatin-induced immune-mediated cytopenias: A case report and literature review. J. Oncol. Pharm. Pract. 21, 148\u2013156. https:\/\/doi.org\/10.1177\/1078155213520262 (2015).","journal-title":"J. Oncol. Pharm. Pract."},{"key":"60603_CR26","first-page":"443","volume":"37","author":"W Yu-meng","year":"2017","unstructured":"Yu-meng, W., Zhi, P. & Ming, L. Oxaliplatin-induced immune pancytopenia: A report of 1 case and literature review. Chin. J. Pract. Surg. 37, 443\u2013446 (2017).","journal-title":"Chin. J. Pract. Surg."},{"key":"60603_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-3-1","volume":"3","author":"AB Marnelli","year":"2010","unstructured":"Marnelli, A. B. et al. Hypersensitivity reaction and acute immunemediated thrombocytopenia from oxaliplatin: Two case reports and a review of the literature. J. Hematol. Oncol. 3, 1\u20138 (2010).","journal-title":"J. Hematol. Oncol."},{"key":"60603_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ajh.20516","volume":"81","author":"BR Curtis","year":"2006","unstructured":"Curtis, B. R. et al. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin. Am. J. Hematol. 81, 193\u2013198. https:\/\/doi.org\/10.1002\/ajh.20516 (2006).","journal-title":"Am. J. Hematol."},{"key":"60603_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1200\/OP.20.00734","volume":"17","author":"K Sullivan","year":"2021","unstructured":"Sullivan, K. et al. Trastuzumab-induced thrombocytopenia correlated by drug-dependent platelet antibodies. JCO Oncol. Pract. 17, 153\u2013155. https:\/\/doi.org\/10.1200\/OP.20.00734 (2021).","journal-title":"JCO Oncol. Pract."},{"key":"60603_CR30","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1111\/trf.16295","volume":"61","author":"M Slaught","year":"2021","unstructured":"Slaught, M., Rasmussen, M., Bougie, D. & Aster, R. Immune thrombocytopenia induced by beta-lactam antibiotics: Cross-reactions of responsible antibodies with other beta-lactam drugs. Transfusion 61, 1600\u20131608. https:\/\/doi.org\/10.1111\/trf.16295 (2021).","journal-title":"Transfusion"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60603-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60603-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60603-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T12:03:20Z","timestamp":1714219400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60603-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,27]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["60603"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-60603-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,27]]},"assertion":[{"value":"29 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9705"}}